Back to Trades
Fernandez Santidrian Antonio
Chief Scientific OfficerCIK 0001990403
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 2
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2025–2026
Fernandez Santidrian Antonio, Chief Scientific Officer, has filed 2 SEC reports (2025–2026), all concentrated in Calidi Biotherapeutics, Inc. (CLDI), totaling $77.1K in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
2 loaded
| Aug 19 | CLDI Calidi Biotherapeutics, Inc. | Fernandez Santidrian Antonio | Chief Scientific Officer | Award | $21.8K |
| Sep 5 | CLDI Calidi Biotherapeutics, Inc. | Fernandez Santidrian Antonio | Chief Scientific Officer | Award | $55.3K |
2 filings